Cybin Inc banner

Company Overview

Business Description

Sector
Health Care
Industry
Pharmaceuticals
Headquarters
Canada CA
Employees
50
IPO date
Jan 5, 2018

In the intricate world of biotechnology, Cybin Inc. emerges as a formidable player, navigating the uncharted waters of psychedelic therapeutics. Known for its innovative approach, Cybin is focused on revolutionizing mental health treatment through the research and development of psychedelic compounds. The company's ambition is to unlock the therapeutic potential of these substances, particularly psilocybin, the active component in magic mushrooms. By employing advanced drug delivery systems and conducting rigorous clinical trials, Cybin aims to optimize the effectiveness and safety of these compounds, addressing complex mental health issues such as depression, anxiety, and addiction.

Cybin operates by transforming its groundbreaking research into viable commercial opportunities, thus fueling its revenue stream. The company's business model is primarily research and development-centric, relying on strategic collaborations and proprietary technological advancements to propel its clinical pipelines into the pharmaceutical marketplace. Revenue is generated through partnerships with academic institutions and contract research organizations, as well as through licensing agreements for their patented delivery systems. As Cybin continues to make strides in this nascent field, it positions itself not just as a company, but as a pioneer, boldly charting a new course in the crucial intersection of mental health and biotechnology.

Cybin Inc Investor Relations

Address
5600-100 King St West
Toronto, Ontario
Canada

Management

Mr. Eric So L.L.B.

Co-Founder, President & Executive Chairman

Biography unavailable

Mr. Douglas L. Drysdale

Chief Executive Officer

Biography unavailable

Mr. Paul Glavine

Co-Founder, Chief Growth Officer & Director

Biography unavailable

Mr. Greg Cavers

Chief Financial Officer

Biography unavailable

Mr. Aaron Bartlone

Chief Operating Officer

Biography unavailable

Mr. George Tziras

Chief Business Officer & Director

Biography unavailable

Mr. John Kanakis

Co-Founder

Biography unavailable

Dr. Alex L. Nivorozhkin Ph.D.

Chief Scientific Officer

Biography unavailable

Ms. Lori Challenger

Chief Compliance, Ethics & Administrative Officer

Biography unavailable

Mr. Gabriel Fahel

Chief Legal Officer & Corporate Secretary

Biography unavailable

1 / 10